VNDA EBITDA Margin
Vanda Pharmaceuticals Inc · EBITDA Margin
VNDA EBITDA Margin
Latest reported-76.44%period ending
VNDA TTM EBITDA Margin (-2387.69% → -76.44%)
TTM ebitda margin
High-resolution chart · PNG
VNDA ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -76.4423% | |
| -62.5589% | |
| -56.2028% | |
| -44.2496% | |
| -35.2794% | |
| -21.0881% | |
| -7.4402% | |
| -5.6419% | |
| -3.3133% | |
| 0.4003% | |
| 4.8531% | |
| 9.501% | |
| 10.8272% | |
| 10.5548% | |
| 5.5165% | |
| 5.0686% | |
| 6.9906% | |
| 10.2177% | |
| 16.7923% | |
| 17.6803% | |
| 17.2008% | |
| 16.2302% | |
| 12.3207% | |
| 9.9058% | |
| 11.8273% | |
| 12.9862% | |
| 12.7067% | |
| 15.4091% | |
| 13.2908% | |
| 10.2292% | |
| 12.787% | |
| 7.2757% | |
| 1.2931% | |
| -2.0869% | |
| -8.4315% | |
| -6.7953% | |
| -2.6569% | |
| -3.0579% | |
| -4.5906% | |
| -14.4841% | |
| -22.5302% | |
| -24.7321% | |
| -24.2265% | |
| -23.6457% | |
| -20.5736% | |
| -55.2403% | |
| -109.1991% | |
| -125.5382% | |
| -156.9779% | |
| -117.1483% | |
| -56.5217% | |
| -54.2646% | |
| -54.8704% | |
| -69.1156% | |
| -79.7415% | |
| -76.8514% | |
| -71.0725% | |
| -52.6888% | |
| -29.386% | |
| -8.4733% | |
| 3.0623% | |
| 11.7266% | |
| 28.6021% | |
| 0.3479% | |
| -31.2054% | |
| -127.0763% | |
| -760.9837% | |
| -1,458.4756% | |
| -1,925.3631% | |
| -2,280.9234% | |
| -2,387.6938% |